Events & Presentations

Past Events

Date	Title
Mar 30, 2023 at 8:30 AM EDT	H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference Click here for webcast
Jan 27, 2023 at 8:30 AM EST	Patidegib Acquisition Call Click here for webcast Supporting Materials Patidegib Acquisition Call 1.6 MB

Date	Title
May 15, 2023	Sol-Gel Corporate Presentation
January 27, 2023	Patidegib Acquisition Call
November 10, 2022	Sol-Gel Corporate Presentation
April 18, 2022	Papulopustular Rosacea: Where are we Now & What is New
January 21, 2020	Characterization of Microencapsulated Benzoyl Peroxide (E-BPO) for the Treatment of Papulopustular Rosacea
January 21, 2020	Efficacy and Safety of Microencapsulated Benzoyl Peroxide (E-BPO) Cream, 5% in Papulopustular Rosacea: Results from Two Phase 3, Vehicle-Controlled Trials
January 21, 2020	Twyneo® (Microencapsulated Benzoyl Peroxide 3%, Tretinoin 0.1%) Phase 3 Efficacy and Safety: Results from Two Randomized Controlled Clinical Trials
January 8, 2020	Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne
July 25, 2019	Sol-Gel Technologies Analyst and Investor Day Presentation
July 8, 2019	Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
February 14, 2018	TWIN Drug Product Candidate Presentation
February 14, 2018	VERED Drug Product Candidate Presentation